Blincyto 38.5 mcg Injection contains blinatumomab, a prescription immunotherapy used for certain types of B-cell acute lymphoblastic leukemia (B-ALL). It is a bispecific T-cell engager (BiTE) that helps direct the body’s T cells toward CD19-positive cancer cells.

Blincyto 38.5 mcg is supplied as a powder for solution and is administered by intravenous infusion. Under specialist medical supervision. The treatment schedule and dose depend on the patient’s condition, treatment phase, and oncologist’s prescription.

The Blincyto price in India, Blincyto injection price, Blinatumomab price. Blincyto cost in India may vary based on the supplier, packaging, and availability. Blincyto should be used only as prescribed by a qualified oncology professional.

Product: Blincyto 38.5 mcg Injection
Active Ingredient: Blinatumomab
Strength: 38.5 mcg
Form: Powder for IV Infusion
Drug Class: Bispecific T-cell Engager (BiTE)
Category: Prescription Cancer Immunotherapy